Inozyme Pharma Inc. Gains 33.88%
Fri, May 02, 2025 at 07:37 PM

Inozyme Pharma Inc. (INZY:NASDAQ) jumped higher at $1.62, a gain of 33.9%. On Fri, May 02, 2025, INZY:NASDAQ hit a New 2-Week High of $1.62. The stock got featured on our News Catalysts scanner on Wed, Apr 16, 2025 at 03:15 AM in the 'INSIDER' category. From Mon, Apr 21, 2025, the stock recorded 66.67% Up Days and 70.00% Green Days
About Inozyme Pharma Inc. (INZY:NASDAQ)
Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and...
Top 10 Gainers:
- Polyrizon Ltd. (PLRZ:NASDAQ), 298.58%
- Freight Technologies Inc Com (FRGT:NASDAQ), 111.21%
- IBO (Listing Market - NYSE Amex (IBO:NYSEMKT), 87%
- Click Holdings Limited (CLIK:NASDAQ), 59.43%
- Cooper-Standard Holdings Inc. (CPS:NYSE), 43.76%
- Santech Holdings Ltd ADS (STEC:NASDAQ), 38.41%
- FST Corp. (KBSX:NASDAQ), 35.33%
- Classover Holdings Inc. (KIDZ:NASDAQ), 33.96%
- Inozyme Pharma Inc. (INZY:NASDAQ), 33.88%
- Adaptive Biotechnologies Corporation (ADPT:NASDAQ), 33.7%